TY  - JOUR
AU  - Patil, Nikita 
AU  - Gómez Hernández, María De La Almudena
AU  - Baker, Aaron 
PY  - 2022
DO  - 10.1016/j.biomaterials.2022.121865
SN  - 0142-9612
UR  - https://hdl.handle.net/20.500.14352/114095
T2  - Biomaterials
AB  - Objective: While lipid-lowering drugs have become a mainstay of clinical therapy these treatments only slow the progression of the disease and can have side effects. Thus, new treatment options are needed to supplement the effects of lipid lowering...
LA  - eng
M2  - 121865
PB  - Elsevier
KW  - Rhamnan sulfate
KW  - Marine polysaccharides
KW  - Atherosclerosis
KW  - NF-κB pathway
KW  - Inflammation
TI  - Rhamnan sulfate reduces atherosclerotic plaque formation and vascular inflammation
TY  - journal article
VL  - 291
ER  -